Lauro Fabián Amador Medina

ORCID: 0000-0003-4900-4726
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Acute Lymphoblastic Leukemia research
  • Neutropenia and Cancer Infections
  • Childhood Cancer Survivors' Quality of Life
  • Telomeres, Telomerase, and Senescence
  • Hematopoietic Stem Cell Transplantation
  • Hemophilia Treatment and Research
  • Lymphatic System and Diseases
  • Lymphoma Diagnosis and Treatment
  • Angiogenesis and VEGF in Cancer
  • Blood Coagulation and Thrombosis Mechanisms
  • Frailty in Older Adults
  • Coagulation, Bradykinin, Polyphosphates, and Angioedema
  • Acute Myeloid Leukemia Research
  • Hydrogen's biological and therapeutic effects
  • Pneumocystis jirovecii pneumonia detection and treatment
  • CNS Lymphoma Diagnosis and Treatment
  • Peripheral Artery Disease Management
  • Cancer-related gene regulation
  • Trace Elements in Health
  • COVID-19 and healthcare impacts
  • Mesenchymal stem cell research
  • Chronic Lymphocytic Leukemia Research

Mexican Social Security Institute
2024-2025

Universidad de Guanajuato
2024

Hospital Regional de Alta Especialidad del Bajío
2021-2023

Recent studies have demonstrated the effectiveness, safety, and tolerability of deferasirox in patients peritoneal dialysis, however, its effect has not been studied undergoing hemodialysis. To investigate impact iron chelation on telomere length, oxidative stress, ferritin levels This is an open-label study, with a control group hemodialysis, who will receive treatment 15mg/kg/day for 6 months chelation. Telomere length was measured using real-time PCR. Serum oxidation markers were...

10.1016/j.nefroe.2025.01.003 article EN cc-by-nc-nd Nefrología (English Edition) 2025-01-01

The COVID-19 pandemic is a colossal challenge for global health; nonetheless, specific subgroups face considerably higher risks infection and mortality. Among patients with malignant diseases, those hematologic neoplasms are at risk poor outcomes. objective of this study was to register treatment modifications associated the their short-term consequences in Latin America.Multicenter, prospective, observational, cohort including older than 14 years from centers four countries (Mexico, Peru,...

10.1200/go.20.00620 article EN cc-by-nc-nd JCO Global Oncology 2021-04-23

Background: Recent studies have demonstrated the effectiveness, safety, and tolerability of deferasirox in patients peritoneal dialysis, however, its effect has not been studied undergoing hemodialysis. Objective: To investigate impact iron chelation on telomere length, oxidative stress, ferritin levels Methods: This is an open-label study, with a control group hemodialysis, who will receive treatment 15mg/kg/day for 6 months chelation. Telomere length was measured using real-time PCR. Serum...

10.1016/j.nefro.2024.06.006 article EN cc-by-nc-nd Nefrología 2024-06-01

10.1016/j.jtct.2023.12.464 article EN cc-by-nc-nd Transplantation and Cellular Therapy 2024-02-01

Acute lymphoblastic leukemia (ALL) is a malignant proliferation of lymphoid cells (lymphoblasts) that can be precursors B or T cells. The most frequent age onset 1-4 years and in adolescents young adults 15-39 old. disease response regulated by heterogeneity, biology, risk factors, chromosomal rearrangements, structural variations, contact sequences alter the lineage's maturation; causes cell activation alterations its regulation. introduction schemes based on L-asparaginase, use tyrosine...

10.34141/ljcs6848397 article EN Latin American Journal of Clinical Sciences and Medical Technology 2023-03-08
Coming Soon ...